Related Experiment Videos
Glucagonoma presenting as morbid obesity
F M Martin1, W Hamilton, R Dons
1Department of Surgery, Naval Hospital, Bethesda, MD 20814.
Journal of Surgical Oncology
|December 1, 1988
Summary
Glucagonoma syndrome, a rare condition, can occur in patients with morbid obesity. Diagnosis requires identifying a glucagon-secreting tumor, elevated glucagon levels, and specific clinical signs, even with weight gain.
Area of Science:
- Endocrinology
- Oncology
- Dermatology
Background:
- Glucagonoma syndrome is a rare neuroendocrine tumor syndrome.
- It is characterized by a glucagon-secreting tumor, typically arising from the pancreas.
- Classic diagnostic criteria include hyperglucagonemia and specific clinical manifestations.
Observation:
- This report details the only known case of glucagonoma syndrome co-occurring with morbid obesity.
- The patient presented with features suggestive of glucagonoma despite significant weight gain.
Findings:
- The presence of a glucagon-secreting tumor was confirmed.
- Hyperglucagonemia was identified in the patient.
- Clinical manifestations including necrolytic migratory erythema, glucose intolerance, and hypoaminoacidemia were observed, aligning with diagnostic criteria.
Implications:
- The findings suggest that glucagonoma syndrome should be considered in the differential diagnosis of patients with unexplained weight gain and classic glucagonoma symptoms.
- This case broadens the understanding of glucagonoma syndrome presentation.
- Further research may explore the interplay between obesity and glucagonoma development or presentation.